INS and type 2 diabetes mellitus: A small retrospective longitudinal study based on 20 elderly (>70 y/o) hospitalized patients with T2D showed a small but statistically significant increase in ASM in the group treated with GLP‐1RA and insulin (glargine + lixisenatide) in co‐therapy for 9 days (plus physical training 3 times a week) compared to the group treated with insulin only.